Regenxbio Inc (RGNX)

7.63 +0.22 (+2.97%) USD  |  NASDAQ  |  Dec 20, 16:00
7.71 +0.08 (+1.05%) After-Hours: 20:00
More

Regenxbio Price to Book Value: 1.254 for Dec. 20, 2024

Price to Book Value Chart

View Price to Book Value for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Catalyst Pharmaceuticals Inc 3.838
Vertex Pharmaceuticals Inc 6.545
Sarepta Therapeutics Inc 9.307
Edgewise Therapeutics Inc 5.954
Entrada Therapeutics Inc 1.559

Price to Book Value Related Metrics

PS Ratio 4.324
Price 7.63
Earnings Yield -65.79%
Market Cap 378.03M